Skip to content

Docteur Bien-Aimé

Active
Private limited companyfounded 2023active for 3 yearsRue du Mistral 46A, 1400 Nivelles, BelgiumKBO/BCE: BE 0797.679.696
Summary

Docteur Bien-Aimé has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €37,146 and a net result of €123,751. Equity has been growing by about 23% per year since 2023. Its solvency ranks better than 20% of 20,700 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 26-01-2023 Normal situation
Activity
General medical practice NACE 86210
Establishment unit
2.340.932.177 1400 Nivelles, since 02-02-2023
Financial year end
31 December
Peppol
Reachable since 21-07-2025

Board and ownership

Board

Financial position

93 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€235,334
▲ 62.3%
Turnover
≈ €430,000
estimated
Profit
€123,751
▲ 86.0%
Equity
€37,146
▲ 11.2%
Total assets
€176,939
▲ 32.3%
Employees on 31-12-2025
1
=
Score breakdownlowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 1.12, cash €128,642Size: total assets €176,939Figures for financial year 2025 (filed on 30-06-2026)Show the evidence

Checked score

Score 2025
93 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 47% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 46-4
equity 21.0% of total assets
Liquidity 57-2
short-term debt 79.0% · cash 72.7%
Profitability 100=
return on assets 69.9%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,160 companies, NACE 86, micro)
Last 24 months 12-2024: < 0.1% 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: 0.1%▲ +0.1 percentage points vs 05-2025 07-2025: < 0.1%▼ -0.1 percentage points vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: 0.1%▲ +0.1 percentage points vs 07-2026 09-2026: 0.1%● unchanged vs 08-2026highest value 10-2026: < 0.1%▼ -0.1 percentage points vs 09-2026lowest value 11-2026: < 0.1%● unchanged vs 10-2026lowest value
Credit of up to €3,000 on 30-day terms is acceptable
Liquidity is tight, with a current ratio of 1.12 (1.18 in 2024), below the usual 1.5. Short-term debt is 79% and cash 72.7% of total assets. 79% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 21% of them on solvency, 33% on liquidity, 80% on profitability and 54% on growth.

The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 1.12, cash €128,642
NBB · annual accounts
lowers risk · Size: total assets €176,939
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 30-06-2026)
NBB · annual accounts
raises risk · Weak solvency compared with the sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 20% of 20700 sector peers (2025).
NBB · sector comparison
Position among 20700 sector peers
Solvency
better than 20%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-06-2026, 31 days ahead of the deadline.
NBB · 3 filings
Deviation from the deadline
2025
31 days early
2024
31 days early
2023
33 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 3 accounts on average 32 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 30 June (3 of the last 3 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
03-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since incorporation in 2023.
KBO publications

Key points

  • Positive: Result rose in 2025from €66,539 to €123,751 ▲ 86.0% View

Recent changes

  1. · Gazette deed IncorporationStarting capital €5,000 · Appointment: BIEN-AIME Jovenel (director)
All 6 events

Comparable companies

These companies have the same main activity as Docteur Bien-Aimé: general medical practice (NACE 86210). They are comparable in size and age: total assets between €169,000 and €210,000, founded between 2021 and 2022.

CompanyTotal assetsGross margin
Docteur Bien-Aimé Nivelles€176,939€235,334
BULCKUS Gent€168,755€267,992
Het doktershuis Bilzen-Hoeselt€173,436€205,944
DRCDEVRIES Zonhoven€208,381€253,658
HUISARTS KIMBERLY DEVOS Roeselare€186,593€210,091
Huisarts Ann-Sophie Odeurs Sint-Niklaas€210,190€233,200
Dinata As€177,020€206,155
Full comparison

Key facts about Docteur Bien-Aimé

What is the company number of Docteur Bien-Aimé?
The company number of Docteur Bien-Aimé is 0797.679.696. The VAT number is the same number with BE in front: BE 0797.679.696.
Where is Docteur Bien-Aimé based?
The registered office is at Rue du Mistral 46A, 1400 Nivelles.Company details
What does Docteur Bien-Aimé do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of Docteur Bien-Aimé?
The legal form of Docteur Bien-Aimé is Private limited company (BV).
When was Docteur Bien-Aimé founded?
Docteur Bien-Aimé was founded on 26-01-2023.
Is Docteur Bien-Aimé still active?
Yes, Docteur Bien-Aimé is an active enterprise in the KBO register.
How many employees does Docteur Bien-Aimé have?
Docteur Bien-Aimé had an average of 1 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of Docteur Bien-Aimé?
The turnover in financial year 2025 is ≈ €430,000. This figure is estimated from the gross margin of €235,334 and 30 comparable companies (NACE 86210). It probably lies between €340,000 and €530,000.
Is Docteur Bien-Aimé profitable?
In financial year 2025, Docteur Bien-Aimé made a profit of €123,751.
Where can I find the annual accounts of Docteur Bien-Aimé?
Docteur Bien-Aimé filed 3 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Docteur Bien-Aimé due?
Docteur Bien-Aimé must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.